Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Judge Denies Amgen’s Request to Block Novartis’s Biosimilar of Neupogen

wsj.com — A federal judge denied Amgen Inc.'s request to block Novartis AG from selling a copy of an Amgen drug for chemotherapy patients in the U.S. U.S. District Judge Richard Seeborg in San Francisco issued an order Thursday finding that Novartis's Sandoz division was "within its rights" not to disclose certain information to Amgen about Novartis's proposed copy of the biotechnology drug, Neupogen, according to a court document.

Lilly joins with Chinese biotech to develop, market cancer drugs

marketwatch.com — Eli Lilly & Co. agreed to form one of the broadest collaborations to date between a large Western drug maker and a Chinese biotechnology company, a sign of the pharmaceutical industry's interest in the Chinese market despite recent growing pains.

Lilly Joins With Chinese Biotech to Develop, Market Cancer Drugs

wsj.com — Eli Lilly & Co. agreed to form one of the broadest collaborations to date between a large Western drug maker and a Chinese biotechnology company, a sign of the pharmaceutical industry's interest in the Chinese market despite recent growing pains.

The Mystery of Duffy's Cut

wsj.com — MALVERN, Pa.-Frank and Bill Watson recently led a group hoisting shovels and pick axes into a wooded hollow here in Philadelphia's suburbs. "Let's find some bodies," said Bill Watson, a professor of history at nearby Immaculata University.

Weight-Loss Drugs Seek Acceptance From Patients and Physicians

wsj.com — U.S. regulators late last year approved Saxenda, the latest in a new generation of weight-loss medications that work by suppressing appetite and making a patient feel full. Saxenda, from Novo Nordisk A/S, hasn't hit pharmacies yet.

Cancer Survival Boosted by Tetanus Shot With Vaccine

wsj.com — A common tetanus booster shot given before an experimental cancer vaccine prolonged survival of patients with a deadly form of brain cancer, a small study found. Duke University researchers who led the study say the regimen could mark a new way to stimulate the body's immune system to attack tumors, a growing area of interest in cancer treatment.

AbbVie to Buy Pharmacyclics in $21 Billion Deal

wsj.com — AbbVie Inc. said late Wednesday it will buy cancer biotech Pharmacyclics Inc. in a $21 billion deal that returns the Chicago drug company to deal-making after backing away from a big tax-lowering takeover last year.

Generic Copies of Remicade Go on Sale in Europe

wsj.com — Generic-drug makers have begun selling lower-priced copies of the blockbuster anti-inflammatory drug Remicade throughout Europe in recent days, a milestone in the emerging market for so-called "biosimilars," or generic versions of complex biotechnology drugs. An approaching wave of biosimilars in Europe and the U.S.

Painkiller in short supply following Hospira recall

marketwatch.com — A generic painkiller widely used in hospitals is in short supply after Hospira Inc. recalled more than 60 lots of vials due to contamination by crystal particles that could cause problems if injected into patients.

Painkiller in Short Supply Following Hospira Recall

wsj.com — A generic painkiller widely used in hospitals is in short supply after Hospira Inc. recalled more than 60 lots of vials due to contamination by crystal particles that could cause problems if injected into patients.
More Articles →
Mar 31, 2015

Eli Lilly's Lechleiter, 8 other CEOs Call on Gov. Pence to Revise Indiana Law $LLY on.wsj.com/1xukWTw via @WSJ

Mar 31, 2015

Jury question from Pao-Kleiner trial was: 'Would you pls describe thought leadership again?' What would they make of 'key opinion leader'?

Mar 31, 2015

Pharma wooing of doctors too... RT @ShiraOvide Explaining the tech industry, in a sentence. MT @JeffElder: Jury note from Pao-Kleiner

Mar 31, 2015

Street crossing tip: 'Eye contact has been shown to enhance perception of a person’s status and dominance' on.wsj.com/1abnKuF via @WSJ

Mar 31, 2015

Most caregivers for Alzheimer’s are close relatives. About 40% of them suffer depression on.wsj.com/1yt9YZS via @WSJ @rddysum

Mar 30, 2015

Amgen Loses Another Round in its Battle to Fend Off a Biosimilar Rival $AMGN $NVS on.wsj.com/1NvGTUj via @WSJ @pharmalot

Mar 30, 2015

RT @jonathanrockoff: $UNH to buy $CTRX in $12.8bn deal, enlarging 3d biggest PBM as drug cost-control pressures rise on.wsj.com/1NxMefR by @annawmathews



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.


Share This Profile